EGFR-TKI
4 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Neoadjuvant Afatinib Combination With Chemotherapy for Stage Ⅱa-Ⅲb NSCLC With EGFR Activating Mutation (NCT04470076) | Fifth Affiliated Hospital, Sun Yat-Sen University | 2020-07-10 |
| Apatinib Combined With EGFR-TKI for Advanced Slow-progressed EGFR-TKI Resistant NSCLC (NCT03428022) | Shenzhen People's Hospital | 2017-12-01 |
Track EGFR-TKI automatically
Every clearance here is in the API, with alerts when new ones post.